Work disability in early rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 21, Issue 5 SUPPL. 31, 2003, Pages

  Sokka, Tuulikki ^a,b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Rheumatoid arthritis; Work disability

Indexed keywords

ANTIRHEUMATIC AGENT;

AGING; ARTICLE; COHORT ANALYSIS; DAILY LIFE ACTIVITY; ECONOMIC ASPECT; EDUCATION; FUNCTIONAL DISEASE; HEALTH CARE COST; HEALTH EDUCATION; HUMAN; PHYSICIAN; POLITICS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SOCIAL ASPECT; SOCIETY; SYMPTOMATOLOGY; TREATMENT PLANNING; WORK DISABILITY;

ACTIVITIES OF DAILY LIVING; ADULT; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; EMPLOYMENT; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; QUALITY OF LIFE; RANGE OF MOTION, ARTICULAR; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0142125198     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. YELIN E, MEENAN R, NEVITT M, EPSTEIN W: Work disability in rheumatoid arthritis: effects of disease, social, and work factors. Ann Intern Med 1980; 93: 551-6.
2. MÄKISARA GL, MÄKISARA P: Prognosis of functional capacity and work capacity in rheumatoid arthritis. Clin Rheumatol 1982; 1: 117-25.
3. PINCUS T, CALLAHAN LF, SALE WG, BROOKS AL, PAYNE LE, VAUGHN WK: Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984; 27: 864-72.
4. YELIN E, HENKE C, EPSTEIN w: The work dynamics of the person with rheumatoid arthritis. Arthritis Rheum 1987; 30: 507-12.
5. REISINE ST, GRADY KE, GOODENOW C, FIFIELD J: Work disability among women with rheumatoid arthritis: The relative importance of disease, social, work, and family factors. Arthritis Rheum 1989; 32: 538-43.
6. CALLAHAN LF, BLOCH DA, PINCUS T: Identification of work disability in rheumatoid arthritis: Physical, radiographic and laboratory variables do not add explanatory power to demographic and functional variables. J Clin Epidemiol 1992; 45: 127-38.
7. DOEGLAS D, SUURMEIJER T, KROL B, SANDERMAN R, van LEEUWEN M, van RIJSWIJK M: Work disability in early rheumatoid arthritis. Ann Rheum Dis 1995; 54: 455-60.
8. REISINE S, MCQUILLAN J, FIFIELD J: Predictors of work disability in rheumatoid arthritis patients. Arthritis Rheum 1995; 38: 1630-7.
9. ALLAIRE SH, ANDERSON JJ, MEENAN RF: Reducing work disability associated with rheumatoid arthritis: Identification of additional risk factors and persons likely to benefit from intervention. Arthritis Care Res 1996; 9: 349-57.
10. van JAARSVELD CHM, JACOBS JWG, SCHRIJVERS AJP, van ALBADA-KUIPERS GA, HOFMAN DM, BIJLSMA JWJ: Effects of rheumatoid arthritis on employment and social participation during the first years of disease in The Netherlands. Br J Rheumatol 1998; 37: 848-53.
11. WOLFE F, HAWLEY DJ: The longterm outcomes of rheumatoid arthritis: Work disability: A prospective 18 year study of 823 patients. J Rheumatol 1998; 25: 2108-17.
12. De ROOS AJ, CALLAHAN LF: Differences by sex in correlates of work status in rheumatoid arthritis patients. Arthritis Care Res 1999; 12: 381-91.
13. CHORUS AMJ, MIEDEMA HS, WEVERS CWJ, van der LINDEN S: Work factors and behavioural coping in relation to withdrawal from the labour force in patients with rheumatoid arthritis. Ann Rheum Dis 2001; 60: 1025-32.
14. SOKKA T, PINCUS T: Work disability in U.S. patients with rheumatoid arthritis of less than 3 years' duration in 2001. Arthritis Rheum 2001; 44: S221.
15. ODEGARD S, UHLIG TTU, KVIEN TTK: Predictors for work disability in rheumatoid arthritis patients over a 7-year period. Ann Rheum Dis 2003; 62: 154.
16. KAARELA K, LEHTINEN K, LUUKKAINEN R: Work capacity of patients with inflammatory joint diseases. An eight-year follow-up study. Scand J Rheumatol 1987; 16: 403-6.
17. BORG G, ALLANDER E, BERG E, BRODIN U, FROM A, TRANG L: Auranofin treatment in early rheumatoid arthritis may postpone early retirement. Results from a 2-year double blind trial. J Rheumatol 1991; 18: 1015-20.
18. MAU W, BORNMANN M, WEBER H, WEIDEMANN HF, HECKER H, RASPE HH: Prediction of permanent work disability in a follow-up study of early rheumatoid arthritis: Results of a tree structured analysis using RECPAM. Br J Rheumatol 1996; 35: 652-9.
19. FEX E, LARSSON B, NIVED K, EBERHARDT K: Effect of rheumatoid arthritis on work status and social and leisure time activities in patients followed 8 years from onset. J Rheumatol 1998; 25: 44-50.
20. SOKKA T, KAUTIAINEN H, MÖTTÖNEN T, HANNONEN P: Work disability in rheumatoid arthritis 10 years after the diagnosis. J Rheumatol 1999; 26: 1681-5.
21. ALBERS JMC, KUPER HH, van RIEL PLCM et al.: Socio-economic consequences of rheumatoid arthritis in the first years of the disease. rheumatology 1999; 38: 423-30.
22. BARRETT EM, SCOTT DGI, WILES NJ, SYMMONS DPM: The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study. Rheumatology 2000; 39: 1403-9.
23. NEWHALL-PERRY K, LAW NJ, RAMOS B et al.: Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. J Clin Epidemiol 2000; 27: 1156-63.
24. YOUNG A, DIXEY J, KULINSKAYA E et al.: Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS). Ann Rheum Dis 2002; 61: 335-40.
25. HAKKINEN A, SOKKA T, LIETSALMI AM, KAUTIAINEN H, HANNONEN P: Effects of dynamic strength training on physical function, Valpar 9 work sample test, and working capacity in patients with recent-onset rheumatoid arthritis 3. Arthritis Rheum 2003; 49: 71-7.
26. YELIN E, KATZ P, LUBECK D, WANKE L, BUATTI M: Impact of etanercept (Enbrel) on health care use and employment in early RA. Arthritis Rheum 2001; 44: S152.
27. SOKKA T, PINCUS T: Markers for work disability in rheumatoid arthritis. J Rheumatol 2001; 28: 1718-22.
28. FRIES JF, SPITZ P, KRAINES RG, HOLMAN HR: Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137-45.
29. PINCUS T, SUMMEY JA, SORACI SA JR, WALLSTON KA, HUMMON NP: Assessment of patient satisfaction in activities of daily living using a modified Stanford health assessment questionnaire. Arthritis Rheum 1983; 26: 1346-53.
30. JÄNTTI J, AHO K, KAARELA K, KAUTIAINEN H: Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: A 20 year study. Rheumatology 1999; 38: 1138-41.
31. MEENAN RF, YELIN EH, NEVITT M, EPSTEIN WV: The impact of chronic disease: a socio-medical profile of rheumatoid arthritis. Arthritis Rheum 1981; 24: 544-9.
32. MITCHELL JM, BURKHAUSER RV, PINCUS T: The importance of age, education, and comorbidity in the substantial earnings losses of individuals with symmetric polyarthritis. Arthritis Rheum 1988; 31: 348-57.
33. KOCHEVAR RJ, KAPLAN RM, WEISMAN M: Financial and career losses due to rheumatoid arthritis: A pilot study. J Rheumatol 1997; 24: 1527-30.
34. GABRIEL SE, CROWSON CS, CAMPION ME, O'FALLON WM: Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with non-arthritic controls. J Rheumatol 1997; 24: 43-8.
35. YELIN E: The earnings, income, and assets of persons aged 51-61 with and without musculoskeletal conditions. J Rheumatol 1997; 24: 2024-30.
36. JONSSON D, HUSBERG M: Socioeconomic costs of rheumatic diseases. Implications for techonology assessment. Int J Technol Assess Health Care 2000; 16: 1193-2000.
37. MERKESDAL S, RUOF J, SCHÖFFSKI O, BERNITT K, ZEIDLER H, MAU W: Indirect medical costs in early rheumatoid arthritis -Composition of and changes in indirect costs within the first three years of disease. Arthritis Rheum 2001; 44: 528-34.
38. MAGNUSSON S: Treatment of rheumatoid arthritis - Does it affect society's cost of the disease? Br J Rheumatol 1996; 35: 791-5.
39. PINCUS T, FERRACCIOLI G, SOKKA T et al.: Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: Updating a 1983 review. Rheumatology 2002; 41: 1346-56.
40. SOKKA T, MÖTTÖNEN T, HANNONEN P: Disease-modifying anti-rheumatic drug use according to the 'sawtooth' treatment strategy improves the functional outcome in rheumatoid arthritis: Results of a long-term follow-up study with review of the literature. Rheumatology 2000; 39: 34-42.
41. LEHTINEN K, ISOMÄKI H: Intramuscular gold therapy is associated with long survival in patients with rheumatoid arthritis. J Rheumatol 1991; 18: 524-9.
42. KRAUSE D, SCHLEUSSER B, HERBORN G, RAU R: Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum 2000; 43: 14-21.
43. CHOI HK, HERNÁN MA, SEEGER JD, ROBINS JM, WOLFE F: Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002; 359: 1173-7.
44. PUOLAKKA K, KAUTIAINEN H, MÖTTÖNEN T et al.: Initial aggressive drug treatment with DMARDs prevents work disability in early rheumatoid arthritis. Arthritis Rheum 2002; 46: S375.
45. PINCUS T, GIBOFSKY A, WEINBLATT ME: Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: better treatments but a shortage of rheumatologists. Arthritis Rheum 2002; 46: 851-4.
46. BURGEL BL: Disability behavior: Delayed recovery in employees with work compensable injuries. AAOHN J 1986; 34: 26-30.
47. ANDERSSON B, HÄGERSTRÖM M, NORDH-GRATE K, NORDMARK B, RÖNNQVIST R: Can multidisciplinary team care preserve work capacity for patients with early rheumatoid arthritis ? Ann Rheum Dis 2000; 59: 44.
48. PAIMELA L, PELTOMAA R, LEIRISALO-REPO M: Permanent work disability in patients with early rheumatoid arthritis. Arthritis Rheum 2000; 43: S154.